Clean Science & Technology vs Gem Aromatics: Share Price, Valuation and Results Compared

Clean Science & Technology Ltd (NSE: CLEAN) and Gem Aromatics Limited (NSE: GEMAROMA) are both listed in the Aroma Chemicals industry. Clean Science & Technology has a market capitalisation of ₹7,042 Cr and Gem Aromatics ₹715 Cr, as of 9 Nov 2026. Their P/E ratios are 30.7 and 489 respectively. Return on equity is 15.31% for Clean Science & Technology and 0.32% for Gem Aromatics. Over one year, Clean Science & Technology's share price is down 31.3% and Gem Aromatics's is down 35.8%.

Clean Science & Technology vs Gem Aromatics — Key Figures

MetricClean Science & TechnologyGem Aromatics
NSE SymbolCLEANGEMAROMA
BSE Code543318544491
Share Price₹697.00₹143.99
Market Cap₹7,042 Cr₹715 Cr
P/E Ratio30.7489
Return on Equity15.31%0.32%
Return on Assets10.24%1.93%
Dividend Yield1.21%—
Beta (1Y)0.590.49
1-Year Price Change-31.3%-35.8%
3-Month Price Change-13.3%-20.5%
52-Week Range₹645.05 – ₹963.00₹131.02 – ₹228.00
Latest QuarterQ2 FY27Q2 FY27
Quarterly Revenue₹299 Cr₹104 Cr
Quarterly Net Profit₹56 Cr₹-7 Cr
Net Margin18.6%-6.7%
EPS (Basic, Quarter)₹5.24₹-1.29
Results Basisconsolidatedconsolidated
HeadquartersPune, MaharashtraMumbai, Maharashtra

The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.

About the Companies

Clean Science & Technology Ltd

Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, l-ascorbyl palmi…

Gem Aromatics Limited

Gem Aromatics Limited manufactures and sells specialty ingredients in India, the United States, China, Brazil, Singapore, and internationally. The company offers mint and mint derivatives, such as peppermint, spearmint, and menthol; clove and clove derivatives, including clove oil, and eugenol and eugenol derivatives; phenol comprising anethole; and other ingredients, such as eucalyptus and eucalyptol, lemongrass, and other products for use in oral care, cosmetics, personal care, and other applications. The company was incorporated in 1997 and is headquartered in Mumbai, India.

Frequently Asked Questions

Which is larger by market cap, Clean Science & Technology or Gem Aromatics?

Clean Science & Technology has a market capitalisation of ₹7,042 Cr, against ₹715 Cr for Gem Aromatics as of 9 Nov 2026, about 9.8 times the size by market cap.

What is the P/E ratio of Clean Science & Technology and Gem Aromatics?

Clean Science & Technology has a P/E of 30.7 and Gem Aromatics a P/E of 489 as of 9 Nov 2026.

What is the return on equity of Clean Science & Technology and Gem Aromatics?

Clean Science & Technology has a return on equity of 15.31% and Gem Aromatics 0.32%.

How have Clean Science & Technology and Gem Aromatics shares moved over one year?

Clean Science & Technology's share price is down 31.3% over one year and Gem Aromatics's is down 35.8%.

What were the latest quarterly results of Clean Science & Technology and Gem Aromatics?

Clean Science & Technology reported revenue of ₹299 Cr and net profit of ₹56 Cr for Q2 FY27. Gem Aromatics reported revenue of ₹104 Cr and net profit of ₹-7 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.

Which industry are Clean Science & Technology and Gem Aromatics in?

Both are classified under Speciality Chemicals > Specialty Chemicals > Aroma Chemicals on FinBizNet.

Is this comparison a recommendation to buy or sell Clean Science & Technology or Gem Aromatics?

No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.

More Comparisons

More on FinBizNet

Data as of 9 Nov 2026. Descriptive market data only — not investment advice.